Exploratory Study of EBV DNA Titre Clearance Whilst on Proton Beam Therapy
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age8-30
SponsorThe Christie NHS Foundation Trust
About this trial
How does plasma Epstein-Barr Virus (EBV) DNA level change during definitive radiation therapy for nasopharyngeal carcinoma (NPC) in the teenage and young adult cohort and does it correlate with outcomes?
Eligibility criteria
Qualifiers
Children and young adults (8-30 years old)
Pathologically confirmed EBV-positive nasopharyngeal carcinoma
Stage I-IVA (AJCC 8th Edition)
Planned to commence curative-intent radiation therapy
Disqualifiers
Recurrent NPC
Concurrent or previously treated EBV-associated malignancy
Prior radiation therapy
Contraindications to MRI
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov